Prediction of onset of remnant gastric cancer by promoter DNA methylation of CDO1/HOPX/Reprimo/E-cadherin

MLA

Naoko Minatani, et al. “Prediction of Onset of Remnant Gastric Cancer by Promoter DNA Methylation of CDO1/HOPX/Reprimo/E-Cadherin.” Oncotarget, vol. 10, no. 25, Mar. 2019, pp. 2423–34. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....44d48f2b732c9a944eefad3d934d48f4&authtype=sso&custid=ns315887.

APA

Naoko Minatani, Satoru Ishii, Kei Hosoda, Nobuyuki Nishizawa, Hiromitsu Moriya, Masahiko Watanabe, Hideki Ushiku, Kazuharu Igarashi, Toshimichi Tanaka, Yosuke Ooizumi, Keigo Yokoi, Keita Kojima, Keishi Yamashita, & Hiroaki Mieno. (2019). Prediction of onset of remnant gastric cancer by promoter DNA methylation of CDO1/HOPX/Reprimo/E-cadherin. Oncotarget, 10(25), 2423–2434.

Chicago

Naoko Minatani, Satoru Ishii, Kei Hosoda, Nobuyuki Nishizawa, Hiromitsu Moriya, Masahiko Watanabe, Hideki Ushiku, et al. 2019. “Prediction of Onset of Remnant Gastric Cancer by Promoter DNA Methylation of CDO1/HOPX/Reprimo/E-Cadherin.” Oncotarget 10 (25): 2423–34. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....44d48f2b732c9a944eefad3d934d48f4&authtype=sso&custid=ns315887.